RESEARCH SYMPOSIUM: A REAL TREAT: ADVANCES IN IMPLEMENTATION AND TREATMENT TRIAL METHODOLOGY AND DESIGN FOR CHILD AND ADOLESCENT PSYCHIATRISTS

Abstract

ObjectivesChild and adolescent psychiatrists spend their careers treating children and adolescents struggling with mental illness. Yet in recent years, there have been a number of developments in how we evaluate and implement treatments, including therapy, medications, complementary treatments, and neurostimulation. The AACAP Research Committee Symposium provides an exciting opportunity to learn about these new treatment study approaches. Specifically, our experts will discuss: 1) pragmatic clinical trials (PCTs); and 2) implementation science, and facilitate interaction, so that child and adolescent psychiatrists understand these approaches and how to leverage this information for better patient outcomes.MethodsThis Symposium will include didactic presentations and audience-interaction opportunities on pragmatic clinical trials from Melissa DelBello, MD (Co-leader of the MOBILITY pragmatic clinical trial), and implementation science from Rinad Beidas, PhD (Founder and Director of the University of Pennsylvania Implementation Science Center).ResultsDr. DelBello will use the MOBILITY (Metformin for overweight and OBese chILdren with bIpolar spectrum disorders Treated with second-generation anitipsYchotics) study to explain what a patient-centered outcomes research institute (PCORI) pragmatic trial is, including the potential advantages, differences, and challenges compared to traditional treatment trials. Dr. Beidas will discuss implementation science—the study of methods to improve the adoption, implementation, and sustainment of evidence-based practices—including how it differs from traditional treatment trials. Using examples from her own research, she will illustrate how implementation science can advance evidence-based child and adolescent psychiatry practice.ConclusionsBy understanding implementation science and pragmatic trials, child and adolescent psychiatrists will be better prepared to interpret the next generation of treatment trials, thus providing better patient care to the families we serve.TREAT, P, PPC ObjectivesChild and adolescent psychiatrists spend their careers treating children and adolescents struggling with mental illness. Yet in recent years, there have been a number of developments in how we evaluate and implement treatments, including therapy, medications, complementary treatments, and neurostimulation. The AACAP Research Committee Symposium provides an exciting opportunity to learn about these new treatment study approaches. Specifically, our experts will discuss: 1) pragmatic clinical trials (PCTs); and 2) implementation science, and facilitate interaction, so that child and adolescent psychiatrists understand these approaches and how to leverage this information for better patient outcomes. Child and adolescent psychiatrists spend their careers treating children and adolescents struggling with mental illness. Yet in recent years, there have been a number of developments in how we evaluate and implement treatments, including therapy, medications, complementary treatments, and neurostimulation. The AACAP Research Committee Symposium provides an exciting opportunity to learn about these new treatment study approaches. Specifically, our experts will discuss: 1) pragmatic clinical trials (PCTs); and 2) implementation science, and facilitate interaction, so that child and adolescent psychiatrists understand these approaches and how to leverage this information for better patient outcomes. MethodsThis Symposium will include didactic presentations and audience-interaction opportunities on pragmatic clinical trials from Melissa DelBello, MD (Co-leader of the MOBILITY pragmatic clinical trial), and implementation science from Rinad Beidas, PhD (Founder and Director of the University of Pennsylvania Implementation Science Center). This Symposium will include didactic presentations and audience-interaction opportunities on pragmatic clinical trials from Melissa DelBello, MD (Co-leader of the MOBILITY pragmatic clinical trial), and implementation science from Rinad Beidas, PhD (Founder and Director of the University of Pennsylvania Implementation Science Center). ResultsDr. DelBello will use the MOBILITY (Metformin for overweight and OBese chILdren with bIpolar spectrum disorders Treated with second-generation anitipsYchotics) study to explain what a patient-centered outcomes research institute (PCORI) pragmatic trial is, including the potential advantages, differences, and challenges compared to traditional treatment trials. Dr. Beidas will discuss implementation science—the study of methods to improve the adoption, implementation, and sustainment of evidence-based practices—including how it differs from traditional treatment trials. Using examples from her own research, she will illustrate how implementation science can advance evidence-based child and adolescent psychiatry practice. Dr. DelBello will use the MOBILITY (Metformin for overweight and OBese chILdren with bIpolar spectrum disorders Treated with second-generation anitipsYchotics) study to explain what a patient-centered outcomes research institute (PCORI) pragmatic trial is, including the potential advantages, differences, and challenges compared to traditional treatment trials. Dr. Beidas will discuss implementation science—the study of methods to improve the adoption, implementation, and sustainment of evidence-based practices—including how it differs from traditional treatment trials. Using examples from her own research, she will illustrate how implementation science can advance evidence-based child and adolescent psychiatry practice. ConclusionsBy understanding implementation science and pragmatic trials, child and adolescent psychiatrists will be better prepared to interpret the next generation of treatment trials, thus providing better patient care to the families we serve.TREAT, P, PPC By understanding implementation science and pragmatic trials, child and adolescent psychiatrists will be better prepared to interpret the next generation of treatment trials, thus providing better patient care to the families we serve.